1. Western University of Health Sciences, Graduate School of Biomedical Science, Pomona, CA, United States;
2. Department of Psychiatry Wright University Boonshoft School of Medicine, Dayton, OH, United States;
3. Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, United StatesGenetics of Alcoholism; Neuropsychiatry and Genetics; Nutritional Genetics; Pharmacogenetics
Well-known American Scientist in Psychopharmacology and Psychiatric Genetics.
Distinguished Top Professional to be featured in the Wall Street Journal.
Editor -in-Chief of Current Psychopharmacology, Addiction Psychiatry, and Theranostic and Pharmacological Sciences.
Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health
Regional Editor for Current Pharmaceutical & Biotechnology. Recipient of NIH grants and has been awarded Lifetime Achievements,
Distinguished Honorary Doctors of Humane Letters;
Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary
Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel.
Adjunct professor at Western University, University of Vermont, Wright School of Medicine
Executive Chairman and CEO of TranspliceGen Therapeutics, Inc.
Stanford university credited him as top 2% of the World Best scientist list (2023).
The International Research Awards on Neurology and Neuro Disorders awarded him the “Best Researcher Award 2023”.
Department of Pharmacology & Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, United StatesBehavioral Neuropharmacology; Neuroimaging of Addiction; Biomarkers; Chronic Effects of Methylphenidate on Skeletal Development and Brain Function
Dr. Panayotis K. Thanos, PhD, is a tenured Senior Research Scientist and Research Professor in the Department of Pharmacology and Toxicology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York. He also serves as Director of the Behavioral Neuropharmacology and Neuroimaging Laboratory within the University at Buffalo’s Clinical and Research Institute on Addictions. Dr. Thanos received his PhD in Biomedical Sciences/Neuroscience from Eastern Virginia Medical School/Old Dominion University and subsequently completed advanced training in neuroscience and neuroimaging of drug addiction at Stony Brook University. His research focuses on addiction neurobiology, behavioral neuropharmacology, brain reward mechanisms, and translational neuroimaging, integrating molecular and behavioral approaches with imaging technologies such as positron emission tomography (PET), magnetic resonance imaging (MRI), CT, and autoradiography to investigate the genetic, epigenetic, neurochemical, and functional mechanisms underlying substance use disorders and related neuropsychiatric conditions. His current research encompasses dopaminergic reward signaling in addiction, obesity and binge eating; the effects of GLP-1 interventions and bariatric surgery on brain reward circuitry; long-term consequences of psychostimulant exposure; endocannabinoid signaling in pain and reward; exercise as a potential therapeutic intervention for substance use disorders; and the developmental effects of prenatal nicotine and cannabis exposure. Dr. Thanos has served as principal investigator or co-investigator on numerous projects supported by the NIH, NIDA, NIAAA, and other research agencies. His current Scopus profile lists 259 indexed documents, an h-index of 50, and more than 9,570 citations, reflecting his sustained contributions to addiction neuroscience, reward-system biology, neuroimaging, and translational neuropharmacology.
1. Department of Physics and Astronomy "G.Galilei", University of Padua, Padova, Italy
2. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy
3. Padova Neuroscience Center, Padova, ItalyCharcot-marie-tooth; Parkinson’s Diseases; Bioinformatics; Biology
Associate Professor at the Dept. of Physics and Astronomy, University of Padova
Scientific Cordinator and Executive (VP, SVP, CFO, CTO etc.) of PNC-SISMUR Infrastructure for Cellular Imaging at the Venetian Institute of Molecular Medicine (VIMM), Padova
Group Leader at the Venetian Institute of Molecular Medicine (VIMM), Padova
Centro de Investigación Biomédica en Red de Cáncer, Madrid, SpainIdentification of new genes involved in cancer; Its characterization and translation to clinic; Identification and validation of new targets for anticancer drug discovery
Head of the Assay Development Group at the Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid
Leader of the Molecular Biology of Cancer Lab in Biomedical Institute of Seville (IBiS/CSIC)
1. Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment;
2. Henan Key Laboratory of Cancer Epigenetics;
3. Cancer Hospital, The First Affiliated Hospital（College of Clinical Medicine）of Henan University of Science and Technology, ChinaBasic and Clinical Research on Gastrointestinal Cancer
Deputy Dean, Medical College, Henan University of Science and Technology
President, The First Affiliated Hospital of Henan University of Science and Technology
President, Cancer Hospital, The First Affiliated Hospital of Henan University of Science and Technology
Editor-in-Chief, Esophageal Cancer and Diseases of the Esophagus
Director, Esophageal Photodynamic Therapy Training Base, China
Director, Henan Provincial Key Laboratory of Epigenetics
Director, Henan Provincial International Joint Key Laboratory of Infection and Esophageal Cancer
Director, Henan Provincial Engineering Research Center for Esophageal Cancer Prevention and Control
Director, Henan Provincial Academician Workstation for Esophageal Cancer Prevention and Control
Discipline Leader, Medical Bioinformatics Ph.D. Program, Henan University of Science and Technology
Professional Memberships and Leadership Roles:
Member, American Society of Clinical Oncology (ASCO)
Chair, Esophageal Cancer Committee, Chinese Society of Clinical Oncology (CSCO)
Vice Chair, Photodynamic Therapy Committee, Chinese Anti-Cancer Association (CACA)
Vice Chair, Expert Committee on Photodynamic Therapy, Chinese Society of Clinical Oncology (CSCO)
Chair, Henan Provincial Anti-Cancer Association – Esophageal Cancer Committee
Vice Chair, Henan Medical Association – Oncology Committee
Vice President, First Henan Provincial Physicians Association – Oncology Physicians Branch
Vice Chair, Henan Hospital Association – Cancer Hospital/Department Management Branch
Chair, Youth Committee of Henan Provincial Anti-Cancer Association – Precision Medicine
Vice Chair, Henan Provincial Anti-Cancer Association – Chemotherapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Photodynamic Therapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Tumor Epidemiology and Etiology Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Oncologic Endoscopy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Committee on Precision Diagnosis and Treatment
Vice Chair, Henan Provincial Anti-Cancer Association – Targeted Therapy Committee
Vice Chair, Henan Provincial Geriatrics Society – Oncology Committee
Vice President, Luoyang Anti-Cancer Association
Chair, Luoyang Municipal Oncology Committee
School of Basic Medical Science, Henan University, Kaifeng, ChinaMedical Microbiology and Immunology; Nuclear Protein PCNP(PEST proteolytic signal-containing nuclear protein); Tumorigenesis; Tumor Suppression Gene
Professor | Vice Dean, School of Medicine, Henan University
Distinguished Professor, The First Affiliated Hospital of Henan University
Vice President, Henan Immunological Society
Director, Henan International Joint Laboratory of Nucleoprotein Gene Regulation
Founder and First Chairman, Henan Industrial Technology Innovation Strategic Alliance for Precision Diagnosis and Treatment of Cancer
Honorary President, Henan Health Science Society
Chief Science Communicator, Henan Science Communication Expert Group
Founder of the Kaifeng Medical Science Communication Team
Council Member, Chinese Society of Microbiology
Former Vice President, Henan Society of Microbiology
Founder and First Chair, Henan Specialized Committee on Infection, Molecular Immunology
Chair, Sub-committee on Biomedical Research Ethics, Henan University
Founder and First Director, Henan Specialized Committee on Infectious Diseases and Biosafety
Founder and Honorary Director, Kaifeng Key Laboratory of Infectious Diseases and Biosafety
School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.Cell Signaling Transduction; PTEN; CART; Biotechnology
Distinguished Professor, Henan University, Huanghe Scholar
Standing Council Member, Henan Physiological Society
Vice Chair, Professional Committee on Neurobiology
Standing Council Member, Henan Society of Biochemistry and Molecular Biology
Member, Chinese Society of Biochemistry and Molecular Biology
Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Diseases, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, ChinaProtein Medications; Carcinogenesis; Treatment
Professor, Guangzhou Medical University, GuangZhou, China
Deputy Director, Guangdong Provincial Key Laboratory of Protein Modification and Degradation
Council Member, Chinese Pharmacological Society
Standing Council Member, Guangdong Pharmacological Society
Secretary, Specialized Committee on Protein Modification and Disease, Chinese Society of Pathophysiology
Vice Chair, Specialized Committee on Drug Screening and Evaluation, Guangdong Pharmacological Society
1. Biobank of Research, IRCCS Azienda Ospedaliera-Universitaria di Bologna Policlinico di S. Orsola, Bologna, Italy;
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, ItalyLeukemia; Lymphoma; Targeted therapy; Molecular diagnostics; High throughput genomics; Transcriptomics; Digital pathology
Associate Professor of Pathology & Executive Physician, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya
Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
National Academic Qualification as Full Professor of Pathology
Associate Editor for the American Journal of Blood Research, Modern Chemotherapy, World Journal of Hematology, Frontiers in Molecular Biosciences, Helyon.
Member of the SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL
Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, ItalyWound Healing; Vascular Surgery; Metabolic Syndrome; Treatment; Vascular Medicine; Reconstructive Surgery; General Surgery; Surgery; Diabetes; Atherosclerosis
Associate Professor of Vascular Surgery at the University Magna Graecia of Catanzaro, Catanzaro, Italy
Full Professor of Surgery and Vascular Surgery
Academic Head of Calabria Region of Italian Society of Vascular and Endovascular Surgery (SICVE).
"International -1- Member" of the Association for Academic Surgery (AAS).
Holder of “Zaleuco” Prize for Vascular Surgery conferred by Associazione Cenacolo della Cultura e delle Scienze
Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, United StatesDiabetes; Redox Biochemistry; Mitochondrial Oxidative Stress; Acute Kidney Injury; Chronic Kidney Disease
Professor of Pharmaceutical Sciences
Top 2% Worldwide Scientists in the 2024 Edition of Stanford University/Elsevier ranking
Director for a Journal Club Course
Member of American Society for Biochemistry and Molecular Biology
Member of Society for Redox Biology and Medicine
Member of the International Society of Nephrology
Member of the International Society of Neurochemistry
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBasic and clinical applications of tumor immunotherapy and cell therapy
Director and Professor, Zhengzhou University, China
Recipient of the State Council Special Allowance, China
Academic Vice President, Medical School, Zhengzhou University
Chief Scientist, The First Affiliated Hospital of Zhengzhou University
Director, Biotherapy Center and Division of Bioimmunotherapy, The First Affiliated Hospital of Zhengzhou University
Member, European Society of Immunology (ESI); American Association for Cancer Research (AACR); American Association of Immunologists (AAI)
Council Member, Chinese Society of Immunology
Chair, Professional Committee on Biotherapy, Henan Anti-Cancer Association & Henan Society of Immunology
Executive Vice Chair, Cell Therapy Quality Management and Research Branch, China Quality Management Association for Pharmaceuticals
Vice Chair, Biotherapy Branch, Chinese Society of Research Hospitals
Standing Council Member, Committee on Tumor Immunotherapy, Chinese Anti-Cancer Association (CACA)
Committee Member, Immuno-Oncology Committee, Chinese Society of Clinical Oncology (CSCO)
Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, United StatesPsychiatry; Neuroimaging; Molecular Imaging; Addiction Psychiatry; Cognitive; Memory; Consciousness; Brain; Prefrontal Cortex; Genetic Addiction Risk Severity
Professor and Chief of Psychiatry at the VA at The University of Texas Health Science Center at San Antonio.
Prof. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA;
Department of Psychology, Gordon F. Derner School of Psychology, & Department of Biology, College of Arts and Sciences, Adelphi University, Garden City, NY, USAOxidative Stress; Lipid Peroxidation; Biochemistry; Natural Product Chemistry; Medicinal and Pharmaceutical Chemistry; Medicinal Plants; Antioxidant Activity; Antioxidants; Free Radicals; Reactive Oxygen Species
Debasis Bagchi, PhD, MACN, FRSM, CNS, FISNFF, CFFS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is the Director of Innovation & Clinical Affairs, Dr. Herbs LLC, Concord, CA; an Adjunct Professor in the College of Pharmacy & Health Sciences, Texas Southern University, Houston, TX; and a Professor, Faculty in the Department of Biology, Adelphi University, Garden City, NY, and the Course Director of Neurotoxicology (BIO 580); an Adjunct Faculty in the Department of Psychology, Gordon F. Derner School of Psychology, Adelphi University, Garden City, NY, and the Course Co-Director of Integrative Neuroscience Seminar (PIA395-001). Dr. Bagchi is the ex-Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX. He served as the Chief Scientific Officer at Cepham Inc, Belmont, NJ, from June 2013, till Dec 2018, and as the Director of Scientific Affairs, VNI Inc., Bonita Springs, FL, from Jan 2019 to Jan 2023. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 till Feb 2011; Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, till June 2013.
Dr. Bagchi received the Master of American College of Nutrition Award in October 2010; became a Fellow of ISNFF in 2021 and awarded a Fellow of Royal Society of Medicine (FRSM) in 2022. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. Dr. Bagchi has 492 peer reviewed journals, 51 books and 20 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. Dr. Bagchi is the Associate Editors of the Journal of Functional Foods, Journal of the American College of Nutrition, and Archives of Medical and Biomedical Research, and serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Food & Nutrition Research, Toxicology Mechanisms and Methods, The Original Internist, and other peer reviewed journals.
Imperial College London, Department of Surgery and Cancer, London, United KingdomNon-coding; Transcription; miRNA; lncRNA; Cancer Regulation
Dr Leandro Castellano obtained his Master Degree in Biology in Biology at the University of Salento, Italy. He then moved to Rome at the University “La Sapienza” where he completed a PhD in Human Biology and Genetics (2003-2007) working during the first year on the role of Post Transcriptional Gene Silencing (PTGS) in the Circadian Rhythm of the filamentous fungus Neurospora Crassa and later, on the role of microRNAs in human Cell Cycle and in Chronic Lymphocytic Leukaemia (CLL).
He moved to Imperial College London in 2007 where he worked as a Research Associate focusing on the role of microRNAs in epithelial cancers. From 2011 he was appointed as Team Leader at the Division of Surgery and cancer, at Imperial, where he directly supervised several PhD students, Research Associates and Research Assistants. During these years Dr Castellano research interests expanded from microRNAs to the role of various classes of short and long non-coding RNAs in epithelial cancer development and progression.
He is the Head of Department of Biochemistry and Biomedicine and a Reader (Associate Professor) in RNA Biology at the University of Sussex and holds an honorary position at Imperial College London as visiting Reader.
He is the co-Director of the Sussex RNA Research Centre (https://www.bsms.ac.uk/research/clinical-and-experimental-medicine/rna-biology-research-group/index.aspx)
He is the Designated Individual (DI) under the Human Tissue Act at the School of Life Sciences at the University of Sussex.
He is a fellow of the higher education academy (FHEA).
For more information about our research see the Castellano Lab website:
https://www.sussex.ac.uk/research/labs/castellano-lab/
Editorial Board
- Associate Editor, “Oncogene” (Springer Nature)
- Associate Editor "Cancer Gene Therapy" (Springer Nature)
- Editorial Board "Non-coding RNA" (MDPI)
- Editorial Board, “Non-coding RNA Research” (KeAi publishing, Elsevier)
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.Genomics; Proteomics; Drug repurposing; Bioinformatics; Next-generation sequencing; Cancer biomarker; Evidence-based medicine; Extracellular vesicles; MicroRNA; Molecular diagnostics; Non-coding RNAs; Nasopharyngeal carcinoma; Non-small cell lung cancer
Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.
Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, ChinaNano Functional Materials; Nano Image Probes; Intelligent Diagnosis and Treatment Instruments; Gastric Cancer Early Warning and Early Theranostics System; Nano Therapy Technology Development and Transformation
Distinguished professor of Shanghai Jiaotong University, Shanghai, China.
Dr. Cui is currently a distinguished professor of Shanghai Jiaotong University, vice dean of Translational Medicine Research Institute of Shanghai Jiaotong University, the head of the Nano-Biotechnology Research Institute, Assistant Dean of the Institute of Micro-and Nano-technology, PhD supervisor, Deputy Director of the key laboratory of thin-film micro-technology, winner of the National Fund for distinguished young scholars, and Chief Scientist of Nano major scientific research projects. His research fields are nano-material synthesis, biological effects and safety evaluation, multifunctional nano-probes and molecular imaging.
Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, Bucuresti, RomaniaIschemic Heart Disease; Atherosclerosis; Molecular Mechanisms of Acute coronary Syndromes; Arterial Hypertension; Hypertensive Target Organ Damage
Maria DOROBANTU, MD, PhD, FESC, FACC Emeritus Professor at the University of Medicine and Pharmacy Carol Davila Bucharest Past Chair of the WG6 of ESC (Chair 2016-2018) Ex officio member of the Board of ESH, (Representative with National Societies) from 2019 Member of the ESH Board as a Representative of the National Societies of Hypertension (2019-2021 ) President of ISH RAG Europe(since 2024) Corresponding Member of the Romanian Academy Associate Member of National Academy of Medicine, France Member of the Romanian Academy of Medical Sciences Member of the Academia Europaea My special fields are Microcirculation, ACS and Hypertension Publications in these fields in EHJ, IJC, JH, Lancet, NEJM, Echocardiogragy, RJC, JHR, etc Books in Springer Publishing House as co-edithor (Hypertension and HF, Microcirculation, New Insights in HF, etc) in Romanian Academy Publishing House (5 books one awarded with the Romanian Academy Prise) Medical Publishing House, etc HIRSCH Index 46 (21,113 citat
Nutrigenomics and Growth Biology Laboratory, Washington State University, Pullman, United StatesNutrigenomics; Stem cell; Adipose and Muscle Development; Obesity and Diabetes; Exercise
Regents Professor and Endowed (Funded) Chair in Nutrigenomics and Growth Biology, Department of Animal Sciences, Washington State University, Pullman, WA.
AWARDS, HONORS AND OTHER EXPERIENCES:
- Elected to the Washington State Academy of Sciences, 2024.
- Regents Professor, Washington State University, 2023-Current.
- The American Society of Animal Science (ASAS) Award in Animal Physiology and Endocrinology, 2019.
- Faculty Excellence in Research Award, College of Agricultural, Human, and Natural Resource Sciences, WSU, 2018.
- The American Society of Animal Science (ASAS) Award in Animal Growth and Development, 2017.
- Distinguished Service Award, Physiological Genomics Group, American Physiological Society, 2017.
- Standing Member, NIH-NIDDK, (Diabetes, Endocrinology, and Metabolic Diseases B, DDK-B) Study Section (2016-2020).
- Fulbright Specialist, Institute of International Education (IIE), the U.S. Department of State, Washington, DC. 2016-2021.
- Ad hoc Member, NIH-NIAMS, Special Emphasis Grant Review Panel (ZRG1), 2009-2017.
- Invited Speaker, the Celebration of Science Week, Purdue University, West Lafayette, IN, May 9 -11, 2012.
- Early Career Achievement Award, American Society of Animal Science, 2010.
- Outstanding Advisor Award, College of Agriculture, University of Wyoming, 2008.
- Young Scientist Award, Western Section American Society of Animal Science, 2008.
- Research Award, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, 2007.
- Research Career Enhancement Award, American Physiological Society, 2006.
- Postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC), 2001.
- Research Excellence Award, Graduate College, Iowa State University, 2001.
- Thomas Sutherland Graduate Award for Excellence, Department of Animal Science, Iowa State University, 2001.
- Wilma D. Brewer Award for Excellence in Scientific Writing, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Verba S. And Verner H. Nielsen Scholarship Fund, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Member of national honor society of agriculture, USA: GAMMA SIGMA DELTA.
- David R. Griffith Research Excellence Award, Nutritional Sciences Council, Iowa State University, 2000.
- Ned S. & Esther Raun Graduate Scholarship, Department of Animal Science, Iowa State University, 2000.
- Ensminger Scholarship, Department of Animal Science, Iowa State University, 1999.
International Head and Neck Scientific Group, Padua, Italypromotion of international cooperation in head and neck surgery, oncology and cancer research.
Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.
Dr. Alfio Ferlito received many honors and awards during his career. He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.
School of Pharmacy, University of Camerino, Camerino (MC), ItalyEpigenetics and Neurodegeneration; Nutrigenomics; Xenobiotics and Redox System
Full Professor of Biochemistry, University of Camerino, Italy.
Prof. Rosita Gabbianelli is Full Professor in Biochemistry (BIO/10, Biochemistry) at University of Camerino, Italy from June 2021. She teaches Molecular Biology and Nutrigenomics at the Bachelor degree Course and Master degree course of Chemistry and Pharmaceutical Technology of Faculty of Pharmacy in UNICAM, Italy. Invited professor of Biochemistry at the Jilin Agricultural University, Changchun, China (from 2015). Invited Professor in Nutrigenetics and Nutrigenomics, at the University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Department/Unit of Food Science, CLUJ-Napoca, Romania (from 2015) and at ISS-ISEP, Porto, Portugal. Teaching activity on Nutrigenomics at University of Pharmacy-Hanoi, Vietnam, Quy Nhon University, Vietnam and Pemba, Tanzania (2017).
Prof. Rosita Gabbianelli cooperates as Guest Editor of Antioxidants, J Nutrigenet Nutrigenomics, Mech Ageing Dev, and she is a Member of review panels of several journals on health. She is Reviewer of theEuropean Commission (EX2006C200916) H2020-SC1-2019-SINGLE-STAGE-RTD, the Reprise - Register of Expert Peer Reviewers For Italian Scientific Evaluation, the STSM Cost Action NutRedOx and the Czech Science Foundation. She is Italian MC Member of DEVoTION CA18211 and HyperChildNET CA19115, and Action participant in NutRedOx CA16112 and Epichembio CM1606. Prof. Rosita Gabbianelli is the Chair of the Scientific and Organizing Committee of the European Summer School on Nutrigenomics (from 2014).
Her research field includes the study of genetic and epigenetic mechanisms associated to the development of neurodegeneration induced by early life exposure to food pesticides and nutrigenomic strategies to counterbalance neuronal damage. Her expertise is documented by 118 peer-reviewed publications, 4 book chapters and 133 abstracts to international meetings.
Amsterdam UMC - University of Amsterdam, Amsterdam, NetherlandsAdvanced molecular cancer diagnostics and cell and gene therapy, molecular cancer research
Medical biologist with a career in clinically important cancer research. Scientific knowledge ranging from fundamental to clinical topics, therapy development, and diagnostics. Industry experience in research, development, manufacture, and QA/QC. Specialized in novel technologies, high-throughput analyses and screens, lead prioritization, and validation.
Aristotle University of Thessaloniki, School of Pharmacy, Thessaloniki, GreeceBiologically Active Heterocycles; Thiazole; Thiazolidinone; Benzohiazole; Thiadiazoles with Antimicrobial Activity; COX/LOX; PTP1b; HIV RT Enzyme Inhibitors; Antiinflammatory
Associate Professor, Aristotelian University of Thessaloniki Greece.
Natural Products of Uzbek Academy of Science. In 1977 she defended her PhD thesis and received the Ph.D grade in Chemistry (Ph.D, Doctor of Philosophy in Chemistry). In 1984 she graduated from the School of Pharmacy of Aristotle University of Thessaloniki. From 2006-2013 she served as Head of the Department of Pharm.Chemistry. Since 2010 she has been Full Professor on Medicinal Chemistry for School of Pharmacy at Aristotle University of Thessaloniki. During 2009-2011 she was Vice President of School of Pharmacy at Aristotle University of Thessaloniki.In July 2013 Prof.Geronikaki was elected as a Full member of the Mediterranean Academy of Science and Arts.Her scientific interest is Chemistry of natural products isolation, determination of the structure; Chemistry of biologically active compounds and evaluation of their activity, using different computational methods.
Jonsson Comprehensive Cancer Center, California Nanosystems Institute, Division of Oral and Systemic Health Sciences, School of Dentistry, University of California, Los Angeles, United StatesCancer; Biochemistry; Genetics and molecular Biology; Cancer metabolomics/proteomics; Cancer stem cells; Sjogren’s syndrome; Burning mouth syndrome and chronic pain
Professor at University of California, Los Angeles, United States.
Dr. Hu is a Professor and was previously the MS Program Advisor in the Division of Oral and Systemic Health Sciences at the UCLA School of Dentistry. He has managed the Oral Biology MS program since 2011. Dr. Hu is also a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and currently serving as an editorial board member for multiple international journals. He recently edited the Cancer metabolomics: Methods and Applications for Springer Advances in Experimental Medicine and Biology book series.
Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, IranGenetics and Molecular Epidemiology; Cancer Biology; Epigenetics in Epidemiology; Cell Signaling; Virology; Genomic Surveillance in Public Health; Biomarker Development; Animal Models; Drug Discovery
Researcher, Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Kiavash Hushmandi is a researcher with academic interests in urological diseases, cancer biology, molecular oncology, and translational therapeutic strategies. His research focuses on the molecular mechanisms of cancer progression, tumor microenvironment remodeling, cancer immunotherapy, and emerging therapeutic approaches for urological and hematological malignancies.
His recent work has addressed topics including kidney, bladder, and prostate cancers, bispecific antibodies, CAR-T cell therapy, cancer vaccines, drug delivery systems, nanomedicine-based therapeutic strategies, and molecular pathways involved in disease progression. He has also contributed to studies in public health, cancer epidemiology, renal disease, diabetes-related mechanisms, and cardiorenal therapeutic targets.
Through interdisciplinary research spanning oncology, nephrology, urology, molecular medicine, and pharmacological therapeutics, Kiavash Hushmandi contributes to the understanding of gene- and protein-related disease mechanisms and the development of innovative approaches for disease diagnosis, prevention, and treatment.
Cancer Biology Laboratory & DBT-AIST International CENter for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Guwahati, Guwahati, IndiaInflammatory Pathways and Chronic Diseases; Cancer Biology and Therapeutics
Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati.
Major research work accomplished at IITG so far:
Institute of Transfusion Medicine and Immunology, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Heidelberg, GermanyCancer Immunology; Diabetes; Regeneratvie Medicine;Innate Immunity; Immunometabolism;
Professor of Cell and Moleculr Biology, University of Heidelberg.
Prof. Kzhyshkowska currently works as a Professor, and the Head of the Department for Innate Immunity and Tolerance at the University of Heidelberg. She mainly focuses on cell biology, inflammation, scavenger receptor, molecular biology, and immunology. Her cell biology research is multidisciplinary, incorporating perspectives in cell surface receptor and nucleotide excision repair, DNA repair protein XRCC4, and homology-directed repair. She studied inflammation and cytokines that intersect with proinflammatory cytokines, implant failure, and implant interaction with host and ex vivo. The various areas that she examines in her molecular biology study include receptor, DNA repair, and interleukin 4. Much of her study explores immunology's relationship to macrophages. Her macrophage research is multidisciplinary, incorporating elements of adipose tissue macrophages and pathogenesis and pathology.
Distinguished Professor, Director, Graduate Institute of Biomedical Sciences, College of Medicine, China Medial University (CMU), Taichung, Taiwan, ChinaNeuropsychopharmacology, Cognitive Neuroscience, Precision Medicine
Professor Hsien-Yuan Lane is affiliated with China Medical University and Hospital. His academic work is related to biomedical research, molecular medicine, and disease-oriented life science. He contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 55, indicating a sustained record of scholarly output and citation impact.
1. Sperimental and Clinical Medicine Department, Faculty of Medicine, University of Foggia, Foggia, Italy
2. Biomedical Center, Applied Physics Laboratory, Via Napoli 20 c/o OO.RR. Foggia, ItalyEnvironmental Toxicology; Ecotoxicology; Cancer Diagnostics, Raman MicroSpectroscopy, FTIR Spectroscopy, Immunofluorescence Microscopy, Material Characterization; Atomic Force Microscopy
Associate Professor in Applied Physics at university of Foggia, Foggia, Italy.
Dr. Maria Lasalvia is currently working as Official Biologist at University of Foggia, Applied Physics Laboratory. She obtained her Ph.D. in Biology from same University. Her main area of interest related to Pharmacology and Toxicology, Biomedical Sciences, Molecular Sciences, Physical Science Engineering, and Environmental Sciences. Her area of expertise includes Biological Research, RAMAN Micro Spectroscopy, Atomic Force Microscopy, Pesticides, Occupational Safety and Health, Cells Culture, Cells Viability Test, FTIR (Fourier Transform Infrared Spectroscopy), Fluorescence Microscopy, Live Cells Analysis, Blood Analysis, Analytical Techniques for Chemical Analysis, and Protein Biochemistry Techniques. She has published 74 research articles in journals and conferences as author/co-author.
Department of traslational medicine, University of Ferrara, Ferrara, ItalyOral Medicine and Biology; Pediatric Dentistry; Molecular Biology of the Oral Cavity; Microbiology of the Oral Cavity in Leukemic Pediatric Patients: PCRealtime Study; Neurophysiological Study of Peripheral Neuropathies of the Oral Cavity; MAPkinases in the Precancerous Lesions of Oral Mucous Membranes
Professor Dorina Lauritano is affiliated with Department of traslational medicine, University of Ferrara, Ferrara, Italy.
Dr. Lauritano's research interests include Oral Medicine and Biology, Pediatric Dentistry, Molecular Biology of the Oral Cavity, Microbiology of the Oral Cavity in Leukemic Pediatric Patients: PCRealtime Study, and Neurophysiological Study of Peripheral Neuropathies of the Oral Cavity. Additional areas listed in the board record include MAPkinases in the Precancerous Lesions of Oral Mucous Membranes. Dr. Lauritano contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 58, indicating a sustained record of scholarly output and citation impact.
Center For Advanced Spinal Surgery, Tucson, AZ, United StatesOrthopedic Surgeons Diagnose; Treat Ailments affecting Muscles; Bones and Joints; Treating Sports Injuries; Degenerative Diseases; Tumors; Infections; Birth Defects
Dr. Kaiuwe Lewandrowski is an orthopedist in Tucson, Arizona and is affiliated with Carondelet St. Mary's Hospital, El Dorado Surgery Center-Tucson and Surgical Institute of Tucson. He received his medical degree from Humboldt University of Berlin- Charite Faculty of Medicine and has been in practice for more than 20 years. Dr. Kaiuwe Lewandrowski has expertise in treating spinal fusion, spinal stenosis and spondylosis, among other conditions - see all areas of expertise. Dr. Kaiuwe Lewandrowski accepts Medicare, Aetna, Humana, Cigna, Blue Cross, United Healthcare - see other insurance plans accepted.
Bristol Myers Squibb, Princeton, United StatesCell Culture; PCR; Western Blot Analysis; Gel Electrophoresis; Cancer Biology; Electrophoresis; DNA Extraction; Cloning; DNA; SDS-PAGE
Director, Bristol Myers Squibb, United States.
Dr. Yan Li is a pharmaceutical scientist with expertise in clinical pharmacology, pharmacometrics, and model-informed drug development. Dr. Li’s research focuses on population pharmacokinetics, pharmacokinetic/pharmacodynamic modeling, exposure–response analysis, and quantitative approaches to support dose optimization and drug development decision-making.
Dr. Li has contributed to pharmacometric and clinical pharmacology studies in oncology and hematology, including research on immunomodulatory and cereblon-modulating agents, population pharmacokinetic modeling, renal impairment assessment, drug disposition, and quantitative strategies for clinical development. Dr. Li’s recent work also includes the application of advanced computational and machine-learning methods to longitudinal PK/PD analysis.
With industry experience at Bristol Myers Squibb, Dr. Li contributes to translational and clinical development programs by integrating pharmacokinetic, pharmacodynamic, biomarker, and clinical data to inform evidence-based drug development, therapeutic optimization, and regulatory-supportive analyses.
Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, United StatesAlzheimer’s Disease; Down Syndrome; Neurodegeneration; Tau; Alternative Splicing; Phosphorylation; Kinase; Phosphatase; TDP-43; Truncation; O-GlcNAcylation; Propagation of Tau Pathology
Professor Fei Liu is affiliated with Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, United States.
Dr. Liu's research interests include Alzheimer’s Disease, Down Syndrome, Neurodegeneration, Tau, and Alternative Splicing. Additional areas listed in the board record include Phosphorylation, Kinase, Phosphatase, and TDP-43. Dr. Liu contributes expertise in translational and mechanistic research relevant to the journal's focus on genes, proteins, disease biology, diagnosis, and therapy. The bibliometric record supplied in the board file lists an h-index of 65, indicating a sustained record of scholarly output and citation impact.
Department of Mathematics and Statistics, University of York, Toronto, CanadaBig data mining in biomedicine; Vaccination; Global health; Biostatistics; Data science
Nicola Luigi Bragazzi got his MD in general medicine and surgery from Genoa University (Genoa, Italy) in 2011, his PhD in biophysics from Marburg University (Marburg, Germany) in 2014 and his specialization in Public Health from Genoa University (Genoa, Italy) in 2017. He is a member of the Cochrane Association (Cochrane Reviewer) for the Cochrane Epilepsy Group. He has been awarded Young Knight of the Italian Republic by the President Carlo Azeglio Ciampi in 2005. Recently, in 2019, he has been nominated as one of the top five biomedical researchers worldwide aged less than 40 years in terms of number of publications, articles in Q1 biomedical journals, total impact factor and h-index. He is currently working on infectious disease and vaccination modelling and big data mining in biomedicine at York University.
School of Basic Medical Sciences, Henan University, Kaifeng, ChinaPhysiology; Receptors; Quantum Dots; Receptor; Opioids; ZnO; G-Protein-Coupled Receptors; Neuropharmacology; Neuropeptides; Pain; Depression
Ph.D., Professor (Associate) at Henan University.
Director of the Institute of Molecular Medicine at Henan University; Recipient of the Henan Province Excellent Young Scientists Fund; Selected for the Henan Province Young Talent Support Program; Young Key Faculty Member of Henan Higher Education Institutions; Kaifeng Science and Technology Innovation Talent; Served as a peer reviewer for the National Natural Science Foundation of China (NSFC),
Review Editor for Frontiers in Genetics, and reviewer for more than 10 academic journals, including Theranostics and Frontiers in Oncology. Also serving as a Young Committee Member of the Chinese Society of Microcirculation, Division of Translational Medicine, Director of the Henan Society for Health Science, and Standing Committee Member of the Henan Society for Infection and Molecular Immunology.
Department of Pharmaceutical Sciences, College of Pharmacy, WSH, University of Nebraska Medical Center, Omaha, United StatesNanomedicine; Biophysics; DNA Replication and Recombination; Protein-DNA Interaction; Chromatin Structure and Dynamics; Alzheimer's Disease; Parkinson's Disease; Amyloid Protein Aggregation; Protein Misfolding; Alpha-Synuclein; Beta Amyloid; Protein–Protein Interaction; Computational Modeling; Nanoimaging; Single-Molecule Biophysics; Force Spectroscopy; Atomic Force Microscopy; AFM
Professor, UNMC Department of Pharmaceutical Sciences.
Dr. Lyubchenko received his doctoral training in Molecular Biophysics at the Moscow Institute of Physics and Technology, a top-ranked School in the former Soviet Union. He developed an active research program in the physical chemistry of nucleic acids at the Institute of Molecular Genetics in Moscow. He received the degree of Doctor of Science (the top scientific degree in the former USSR) for this research. He is currently a professor at Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE. Research in the Lyubchenko lab focuses on understanding fundamental mechanisms underlying health and disease, which are key to developing new and more effective diagnostics and medications. The research is categorized into four broad areas, with interplay and overlap among them (1) Structural genomics in relation to cancer and other diseases, (2) Molecular mechanisms Alzheimer’s, Parkinson’s and other protein aggregation diseases, (3) Protein-DNA interactions for novel approaches for HIV restriction.
1. Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, MA, United States
2. Department of Pharmacology & Toxicology, University of Arizona, Tucson, AZ, United StatesBioinformatics; Machine learning; Deep learning; Genomics; Epigenetics
Research Scientist, Department of Pharmacology & Toxicology, University of Arizona, Tucson, AZ, United States.
Dr. Saurav Mallik is a computational biologist and bioinformatics researcher with expertise in machine learning, data mining, biostatistics, genomics, epigenomics, and biomedical data analysis. His research focuses on the development and application of computational and statistical approaches for analyzing high-dimensional biological and clinical datasets, with particular emphasis on disease classification, biomarker discovery, molecular pattern recognition, and precision medicine.
Dr. Mallik received his Ph.D. in Computer Science and Engineering from Jadavpur University, Kolkata, India, with doctoral research conducted at the Machine Intelligence Unit, Indian Statistical Institute, Kolkata. Before joining the University of Arizona, he held research and postdoctoral positions at Harvard T.H. Chan School of Public Health, the Center for Precision Health at the University of Texas Health Science Center at Houston, and the Division of Biostatistics at the University of Miami Miller School of Medicine.
His research contributions span cancer genomics, DNA methylation and gene expression analysis, graph- and rule-based learning algorithms, multi-omics integration, chronic disease prediction, and machine-learning-driven healthcare analytics. Through interdisciplinary work at the interface of pharmacology, toxicology, computational biology, and biomedical informatics, Dr. Mallik contributes to the advancement of data-driven approaches for understanding disease mechanisms, identifying diagnostic and prognostic markers, and supporting precision therapeutic strategies.
WiscNano, School of Pharmacy,University of Wisconsin-Madison, Madison, United StatesNanoBiomaterials; Advanced Drug/Gene Delivery Systems; Cancer Immunotherapy; Bone/tissue engineering
Dr. Mamidi holds the position of Scientist at WiscNano, School of Pharmacy, University of Wisconsin-Madison (UW-Madison), USA. His primary research focus lies in the innovative development of nano-formulations for co-drug-gene delivery and cancer immunotherapy. Prior to his affiliation with UW-Madison, Dr. Mamidi served as an Assistant Professor in the Department of Chemistry and Nanotechnology at Tecnologico de Monterrey (TEC). During his tenure at TEC, he spearheaded multidisciplinary research endeavors that integrated novel chemistries with nanoscale technologies to create advanced biomaterials for diverse biomedical applications. Dr. Mamidi’s team has achieved significant breakthroughs in the design of customizable biomaterials, tailored for applications such as drug delivery, orthopedic implants, tissue engineering, biomedical devices, and environmental remediation. His contributions to the field are well-documented, with over 45 research articles published in prestigious journals. Notably, his work has garnered more than 1000 citations, demonstrating his influential presence in the scientific community.
Acknowledging his outstanding achievements, Dr. Mamidi has received various accolades, including the prestigious 2015 Eli Lilly Award, the 2018 National Research System (SNI) award, and the 2021 SNI award from the National Council for Science and Technology. In recognition of his exemplary contributions, Dr. Mamidi was honored as an outstanding research professor at the School of Engineering and Science, TEC in 2020. Furthermore, Dr. Mamidi actively contributes to the dissemination of knowledge within his domain as an editorial member for several reputable nanomedicine and nanotechnology journals. His dedication to interdisciplinary research and commitment to advancing biomaterials for biomedical applications further underscore his standing as a key researcher in the field.
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyAmyloidosis; Renal Biopsy; Autoinflammatory Diseases; Pathology, Serum; Multiple Myeloma; Rheumatoid Arthritis; Chemotherapy; Oncology; Hematology
Department of Psychology, Curry College, Milton, United StatesGenomics of attention and arousal disorders: ADHD, neurological disorders of attentional deficits (Hemispatial Neglect, Delirium, Parkinson's, TBI); Disorders of arousal and sustained attention (PTSD, anxiety disorders, narcolepsy, sleep and circadian rhythm disorders); epigenetics and pleiotropy; pharmacogenetics
Dr. Modestino is a neuroscientist and licensed mental health counselor. He has an undergraduate degree in psychobiology from Harvard (1997); a master's degree in psychobiology (1999), and a post-master's degree in cognitive neuroscience (2001), both from PENN; a Ph.D. in complex systems and brain sciences (interdisciplinary neuroscience: 2009) from FAU; and a professional master's degree (M.S.) in mental health counseling (2021) from UMass Boston. Dr. Modestino completed two postdoctoral fellowships in neuroimaging: one in psychiatry (UVA: 2010-2012) and another in neurology (BU: 2013-2015). Additionally, Dr. Modestino is licensed as a therapist (LMHC) in MA and RI, board-certified nationally (NCC by NBCC), and a certified clinical supervisor (MCCS) in MA.
Dr. Modestino is a senior lecturer of psychology at Curry College in Milton, MA, USA, where he has taught since 2016, co-directs the EEG Lab, and directs the Brain & Behavior Laboratory. Dr. Modestino also practices as a therapist in private practice.
Dr. Modestino's research broadly encompasses cognitive neuroscience and the brain-behavior relationship using various modalities, including neuroimaging, psychophysiology, neuropsychological assessment, surveys, and genetic studies. One branch of his research focuses on using these modalities to study brain disorders (ADHD, narcolepsy, migraines, Parkinson’s disease), comorbidities (ADHD with comorbid narcolepsy; narcolepsy with comorbid migraines), and cutting-edge psychopathologies [Reward Deficiency Syndrome (RDS) and Rejection Sensitivity Dysphoria (RSD) in ADHD]. A second branch involves studying attentional processes, including in those with ADHD. A third branch involves studying consciousness and religious cognition. Dr. Modestino conducts research at Curry College at The Bruce Steinberg EEG Laboratory, online, and at various institutions with collaborators.
Department of Internal Medicine, University of Genova, Genova, ItalyPharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Doctor of Philosophy, Leading Scientist at Sirius University of Science and Technology.
Dr. Parodi is a biological/medical researcher with significant experience in drug formulation, PK, nanomedicine, drug delivery, and immune metabolism. His research activity is devoted to designing, performing, analyzing, and interpreting data derived from extensive biological testing, material characterization, toxicology, and drug pharmacokinetics.
Key Laboratory of Protein and Peptide Pharmaceuticals, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, ChinaProteins 100; Cancer Associated Fibroblast; Fibroblast Activation Protein Alpha; Tumor Microenvironment
Professor at Zhengzhou University, Researcher at the Institute of Biophysics, Chinese Academy of Sciences, National Science Fund for Distinguished Young Scholars awardee, Chief Scientist of the National "973" Program, and Executive Committee Member of the Tumor Immunology and Biotherapy Branch of the Chinese Society for Immunology. Currently serves as the Director of the Immunology Center at the Medical Sciences Academy of Zhengzhou University and concurrently as the Director of the Medical Research Center at the First Affiliated Hospital of Zhengzhou University.
Institute of Neurophysiopathology (INP), Aix-Marseille University, Marseille, FranceAntimicrobial Peptides; Antibacterial; Antibiotics; Structure-Activity Relationships; Bacteriocins; Drug Design; Peptide Engineering; Antivirals; Infectious Disorders
PhD & HDR, French National Centre for Scientific Research.
Dr. Sabatier is a Director of Research at CNRS affiliated to the Institute of NeuroPhysiopathology, UMR 7051, Marseille (France). He is acting as: Editor-in-Chief of "Journal of Current Toxicology and Venomics"; Editor-in-Chief of "Coronaviruses"; Topic Editor-in-Chief of "Antibiotics" (IF: 4.3); Associate Editor of "Frontiers in Pharmacology" (IF:4.4); Associate Editor of "Journal of Advanced Research" (IF: 11.4); Editorial Board Member of 75 journals. Reviewer for journals with IF up to 35.
Dept. of Applied Sciences, Indian Institute of Information Technology, Allahabad, IndiaBiochemistry; Nanobiotechnology; Bioinformatics
Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyHeart Failure; Atrial Fibrillation; Echocardiography; Electrocardiography; Clinical Cardiology; Chronic Heart Failure; Cardiac Function; Myocardial Infarction; Hypertension; Cardiovascular Medicine
Dr. Sardu is an Associate Professor at the Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy. He authored/co-authored 155 publications and 4739 citations with an h-index of 41 (Scopus, December 2023). His research interests focus on heart failure, atrial fibrillation, echocardiography, electrocardiography, clinical cardiology, chronic heart failure, cardiac function, myocardial infarction, hypertension, and cardiovascular medicine.
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Queenstown, SingaporeCancer cell biology; Cancer therapy (chemotherapy and radiation therapy); Pharmacology and pharmaceutical sciences; Basic pharmacology; Solid tumours; Haematological tumours
Associate Professor at the Yong Loo Lin School of Medicine, Queenstown, Singapore.
Dr. Sethi is the editorial board member of 11 different international journals.
AVAILABILITY
-
Collaborative projects
-
Industry Projects
-
Masters Research or PhD student supervision
-
Join a web conference as a panellist or speaker
-
Mentoring (long-term)
-
Media enquiries
-
Mentoring (short-term)
1. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, India
2. Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab EmiratesCancer Therapeutic; Kinase Inhibitors; Natural Compounds; Protein Biochemistry; Drug Design and Discovery
Dr. Mohammad Anas Shamsi is a Research Assistant Professor at the Center for Medical and Bio-Allied Health Sciences Research. His research area is Structure-based Drug Design and Discovery. He is working in the most exciting areas of medicinal chemistry with a special focus on structure-based drug design and discovery, targeting the discovery of new drugs for the treatment of Cancer and Alzheimer's and related neurodegenerative diseases.
School of Mathematics and Statistics, Henan University, Kaifeng, ChinaSystems Biology; Biostatistics; Omics Data Analysis
Henan Provincial Distinguished Professor, Professor and Doctoral Supervisor at Henan University. Recipient of the Henan Provincial Outstanding Youth Fund, Henan Provincial Excellent Young Scientists Fund, Henan Provincial University Innovation and Technology Talent Program, and Henan Provincial Key Young Faculty Program; Leader of the Kaifeng Municipal Innovative Science and Technology Team.
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou, ChinaImmunology; Molecular and Cellular Biology; Ophthalmology; Cancer Biology
Associate Professor, Senior Investigator, Taishan Scholarship Professor.
Dr. Wang received a Bachelor degree in Basic Medicine from Beijing Medical University (now Health Science Center of Peking University) and a PhD degree in pathophysiology from the Academy of Military Medical Sciences. After postdoc training in the Second Military Medical University and the University of Iowa (1996-2003), he started his career track in the University of Iowa, Shandong Academy of Medical Sciences, Soochow University, Xiamen University and Xi’an Jiaotong-Liverpool University sequentially. His research is to understand the mechanisms underlying the pathogenesis or treatment of diseases from the viewpoints of basic medical scientists. He published over 50 SCI-indexed papers in international journals plus over 50 papers in non-SCI-indexed journals covering immunology, microbiology, molecular biology, cellular biology, pharmacology (disciplines in sense of basic medicine), or hematology, oncology, ophthalmology, dermatology, autoimmune diseases (disciplines in clinical medicine). He also published two books as editors and issued nine inventory patents. He is member of several academic societies and on journal editorial boards. He pursues after novelty in science and enjoys research, especially on innovative theories. In the last ten years, one of his teams interests has been the functions of the gene MXRA7 and disclosed the clues to the significance of this gene in biomedical processes. His team has won several awards from Chinese agents or international academic societies.
1. Department of Biomedical and Clinical Science, University of Milan, Milan, Italy
2. Department of Pediatrics, Buzzi Children’s Hospital, Milano, ItalyPediatrics; Nutrition; Infectious Diseases; Health Care; Telemedicine; Translational Research; Rare Diseases; Non-Communicable Disaeses
Full Professor of Pediatrics at the School of Medicine, University of Milan, Italy
Head of the Department of Pediatrics, University of Milan, at the Children Hospital, Milan, Italy
Director of Pediatric Clinical Research Center
Vice Director of Biomedical and Clinical Science Department Università degli Studi di Milano
Srividya Swaminathan Lab, Department of Systems Biology, City of Hope - Biomedical Research Institute, California, United StatesNK Cells-based Immunotherapy; Acute Lymphoblastic Leukemia; Allergy and Osteoimmunology
B.S., M.S., Ph.D.
Member, American Society of Hematology (ASH) | 2025
DBT International Travel Grant | Govt. of India | 2016
Senior Research Fellowship (CSIR) | Govt. of India | 2014-2019
Junior Research Fellowship (CSIR) | Govt. of India | 2012-2014
Qualified CSIR-JRF Exam (Rank 29) | 2011
Graduate Aptitude Test in Engineering (GATE-2011) | Qualified
National Eligibility Test Lectureship (NET) | Qualified, 2010
Cullen College of Engineering, Houston, United StatesPsychiatric disorders; Monoaminergic systems; GABAergic systems; Anxiety; Stress; Depression; Substance abuse; Genetic basis of emotionality; Developmental basis of Emotionality; Cellular and molecular neuroanatomy of rodent and pstmortem human brain; Light sheet microscopy; Large image-data analysis; Multiplexed fluorescence in situ hybridization; Brain transparency techniques; iDISCO
University of California, Irvine, California, USABioinformatics; Genomics; Proteomics; Single-Cell Multi-omics; and Translational Neuroscience
Dr. Madhu Sudhana Saddala, Ph.D, working as a Bioinformatics Scientist in the University of California, Irvine, CA. USA
Zhejiang Agriculture and Forestry University, Hangzhou, ChinaCardiology; Oncology; Neurology; Vascular Biology; Mitochondria; ROS; Endothelial Function
Professor, College of Forestry and Biotechnology, Zhejiang Agriculture and Forestry University, Hangzhou, China.
Prof. Jin Zhang is a plant molecular biology and forest biotechnology researcher with expertise in wood formation, plant cell wall development, and the molecular regulation of growth and stress responses in woody plants. His research focuses on the genetic and molecular mechanisms underlying xylem differentiation, cambium activity, secondary cell wall biosynthesis, and biomass-related traits, with poplar serving as an important model system.
Prof. Zhang’s work has contributed to the understanding of transcriptional regulation, hormone signaling, calcium signaling, reactive oxygen species homeostasis, and gene regulatory networks involved in wood development and environmental adaptation. His research also addresses drought response, plant productivity, lignin composition, vascular development, and the functional characterization of genes related to woody plant growth.
Through interdisciplinary studies integrating molecular genetics, functional genomics, plant physiology, and forest biotechnology, Prof. Zhang contributes to advancing knowledge of gene- and protein-mediated regulatory mechanisms in plant development and stress adaptation, as well as to the improvement and sustainable utilization of woody biomass resources.